Monthly Archives: December 2013

Fujifilm Displays Advanced Mammography Workstation: Aspire Bellus to Streamline Workflow and Support the Screening and Diagnosis of Breast Cancer at RSNA

The Aspire Bellus, a dedicated breast imaging workstation will be showcased by FUJIFILM Medical Systems U.S.A. Inc. at the 99th annual meeting of the Radiological Society of North America (RSNA) in Chicago, IL. Attendees will be among the first to see the latest addition to Fujifilm’s breast imaging solutions.

“Radiologists require outstanding image quality and highly efficient workflow, and that’s precisely what they get with the Aspire Bellus workstation, which supports the mammography screening and diagnosis of breast cancer,” said David Hotchkiss, director of marketing, Women’s Health, CR, FUJIFILM Medical Systems U.S.A., Inc. “The dedicated breast imaging workstation enables radiologists to easily analyze mammograms and access data that is needed to make confident diagnoses.”

The Aspire Bellus workstation joins Fujifilm’s breast imaging solutions that are designed to improve image quality, streamline workflow and enhance patient outcomes. The workstation is a breakthrough technology offering high quality images, enhanced image reading capabilities, an integrated reporting system and is easy to use. The new features include:
Exceptional display speed of detailed image data;
Customized reading protocols for streamlined reporting workflow;
Intuitive and flexible image layout;
High quality images assisting the user in making an easy and accurate diagnosis
One-click operation for image processing adjustments;
Toggling between current and prior images known as Intelligent Temporal Comparison (ITC)

China Approves Endoscopy Device from Mauna Kea

Mauna Kea Technologies, which develops optical biopsy products, announced today that one of its products, Cellvizio, has received State Food and Drug Administration (SFDA) approval in China, one of the fastest growing, largest medical-device markets in the world. Mauna Kea also announced that it has entered into a strategic partnership with FUJIFILM (China) Investment Co., Ltd., a subsidiary of FUJIFILM Corporation. The partners will work together to develop the Cellvizio market throughout China in various indications.

“We are pleased to add Cellvizio to our broad portfolio of endoscopic products that we offer physicians throughout China,” said Koji Yokota, president of Fujifilm China. “Optical biopsies allow physicians to diagnose and treat their patients in real time and are a true differentiating factor in endoscopy. Cellvizio will complement and enhance our own proprietary suite of advanced endoscopic imaging devices and systems.”

Fujifilm benefits from an exponential growth in its endoscopy market in China and has established strong distribution network all over the country. There are 800 advanced endoscopy centers in tertiary referral hospitals in China, which will constitute the primary target for Cellvizio.

“Fujifilm is the ideal partner to help us penetrate the Chinese market and offer physicians across the most populous country in the world access to Cellvizio,” said Sacha Loiseau, CEO of Mauna Kea Technologies. “Chinese endoscopists have been eagerly waiting for Cellvizio to be available in China. SFDA approval is a significant milestone for the company and strengthens our footprint around the globe, since Cellvizio is now available in more than 40 countries and used by hundreds of physicians.”

Mauna Kea Technologies researches, develops and markets tools to visualize and detect cellular abnormalities during endoscopic procedures. Its flagship product, Cellvizio, a probe-based confocal laser endomicroscopy (pCLE) system, provides physicians and researchers high-resolution cellular views of tissue inside the body. Cellvizio can be used with almost any endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the GI tract, biliary and pancreatic ducts and lungs.

Grand junction gastroenterology endoscopy center

We primarily use two medications to sedate our patients. Fentanyl is given for any discomfort (cramping) you may have. Versed helps patients relax. The combination of these medications helps to make this procedure more comfortable. Dont want to do the bowel prep A good bowel prep is key to a successful colonoscopy. The goal is to clean out the entire large intestine to allow complete visualization. Over the years we have used a variety of bowel preps and feel that our current regime is the safest and most effective at this time. We try to minimize the length of time a patient can’t eat solid food and still allow a good examination. We tell our patients that the short term discomfort of not eating and the process of bowel cleansing are minor compared to the importance of information gained and the potential to prevent colon cancer. Once you start eating normally again after the procedure your bowels quickly return to normal. The Grand Junction Gastroenterology & Endoscopy Center is a State Licensed Facility that meets all the requirements to provide safe, quality health care. Our staff is specifically trained to perform and assist with endoscopic procedures in the area of Gastroenterology. All of our physicians are Board Certified Gastroenterologists.

 

Fujifilm acquires a Turkish sales agency for endoscopy products

FUJIFILM Corporation (President and CEO: Shigetaka Komori) has announced that it acquired 100% equity in Turkey’s sales agency for endoscopy products, FILMED TIBBI CIHAZLAR PAZARLAMA VE TICARET A.S. (hereinafter “FILMED”), through its European subsidiary FUJIFILM Europe GmbH (President: Junji Okada) on February 28. Filmed has now become a wholly-owned subsidiary of Fujifilm. Fujifilm will launch a direct-sales system for endoscopy products in Turkey.
Filmed has long been a distributor of Fujifilm’s endoscopy products to medical institutions across Turkey. With three domestic service stations, the company has a system capable of providing repair services swiftly and reliably. It has also helped many medical institutions adopt Fujifilm’s cutting-edge endoscopy products, thereby contributing to the advancement of digestive endoscopy in Turkey.
In Turkey, which is expected to continue strong economic growth and expansion in the medical equipment market, Fujifilm will take advantage of Filmed’s direct-sales system to make an integrated and swift deployment of its global strategy for endoscopy systems and related products.
Fujifilm is committed to delivering marketing, sales and repair service operations that maintain close connection with the local market and address its diverse needs without delay, so as to expand its endoscopy business in Turkey into the future.

5 Key Trends in GI/Endoscopy

Industry experts discuss the big trends and developments in gastroenterology/endoscopy today and where they are headed in the future.

This article is sponsored by Endoscopy Division FUJIFILM Medical Systems U.S.A., Inc.

Andrew Ross1. New technology in the field. Technology continues to evolve in several ways, according to Andrew Ross, MD, Section Chief, Gastroenterology and Medical Director, Therapeutic Endoscopy Center of Excellence, Virginia Mason Center, Seattle. One of the most important advances is the idea of “optical” histology.

“The concept is really using the endoscope and specialized accessories to make a tissue diagnosis without the need for a direct biopsy and histopathologic confirmation under the microscope,” says Dr. Ross. “While this concept was introduced several years ago with the advent of technology such as ‘FICE’ and narrow band imaging, newer technologies such as confocal laser endomicroscopy really allow for visualization at the cellular level. Whether these devices will replace the need for true tissue biopsy remains a significant open question.”

Another huge technological evolution for gastroenterology/endoscopy is minimally invasive surgical technique. Procedures once requiring open incisions and prolonged recovery times are now performed in endoscopy suites with less invasive procedures.

“The continued understanding of the submucosal space has allowed for the development and clinical implementation of procedures such as endoscopic submucosal dissection for the treatment of early-stage cancers of the GI tract and per-peroral endoscopic myotomy for patients with achalasia.”

2. Proliferation of service agreements. More GI/endoscopy physicians are participating in multi-year service agreements with hospitals than in the past. These agreements should be carefully evaluated on individual merits and cost effectiveness.

“On the other hand, given the rapid pace that healthcare is likely to change over the next three to five years, locking into a fixed service agreement that does not change with technology or with economic pressures (that may come to bear on suppliers of those services) can work against you,” says Barry Tanner, CEO of Physicians Endoscopy. “It is very much like airlines speculating on the future cost of fuel, depending on how much the market drives the price, it can either be a big win or very costly.”

3. Appropriate cleaning, disinfection and sterilization. Cleaning, disinfection and sterilization is important for achieving good outcomes and quality service for patients.

“Consistent with professional organization guidelines including those from SGNA and federal agency recommendations (such as those described in the FDA/CDC/VA Safety Communication entitled Preventing Cross-Contamination in Endoscopy Processing issued November 2009), healthcare facilities should establish Quality Assurance and Safety Programs with an emphasis on endoscopy reprocessing,” says Keith Nelson, Director, Infection Control and Product Development, Endoscopy Division FUJIFILM Medical Systems U.S.A., Inc. “They should also develop institutional Standard Operating Procedures for the reprocessing and storage of flexible endoscopes based upon device manufacturer’s instructions.”

Institutional quality assurance programs should include, but not be limited to:

• Identification of all staff involved in endoscope activities;
• Staff training;
• Annual competency review;
• Availability and dissemination of reprocessing procedures for all endoscopic equipment.
Kurt Cannon
“Overall, we see that in facilities where strict adherence to training and education for dedicated cleaning, disinfection and sterilization exists, not only can additional efficiencies be found, but the frequency of product repair can also be reduced,” says Kurt Cannon, Vice President, Sales, Marketing and Operations, Endoscopy Division FUJIFILM Medical Systems U.S.A., Inc.

4. Electronic data gathering. Physicians and ambulatory surgery centers are now looking to incorporate electronic systems, for electronic medical records or other software for data gathering, which are expensive and take time and energy to implement. However, the right system can have a big impact on performance measurement.

“You need coordinated EMR so you can pull together the results of all the procedures and compare it to the pathology outcome,” says Michael Weinstein, MD, Vice President of Capital Digestive Care and Managing Partner for the Metropolitan Gastroenterology Group Division. “If you don’t have electronic records then you are doing a lot of manual data collection.”

When ASCs and physicians have their data gathered, they can benchmark against industry standards locally and nationwide to see how they measure up and locate areas of improvement based on the comparison.

5. GI Benchmarking. The payment system of the future is moving away from fee-for-service and moving toward a value-based methodology, according to Tom Deas Jr., MD, Medical Director of Fort Worth Endoscopy Center and Past President of American Society for Gastrointestinal Endoscopy. “If you are paying for value, you have to define and measure quality. We are going to develop more advanced and sophisticated ways of doing that and we are going to rely on information technology more. There will be electronic data warehouses for clinical and claims information that can be analyzed and studied to measure and assess quality performance.

“Then we can compare performance against guidelines and see whether physicians completed the guidelines appropriately. They must administer the right tests and medication for diseases and coordinate follow-up and blood work according to the protocols. It’s fairly easy to take claims data and EHR data and determine if treatment was given in an automated way rather than doing chart searches to sort everything out.

“Additionally, we will begin to take this same approach for endoscopic operations. We will look at what it costs to provide various services and benchmark individual performance against others to determine whether we are achieving the highest level of efficiency for the resources spent.”

Fujifilm showcases world premiere for CMOS image sensor in endoscopy at UEGW 2013 in Berlin

The Endoscopy Division of FUJIFILM Medical Systems Europe will showcase a number of advances at the occasion of the UEG week which will be held in Berlin from 12 to 16 October: at booth Nr. 4, Hall 17, the company will display a line-up of new products and will provide lectures on latest technological advances.

Fujifilm is proud to make use of the over-megapixel customised CMOS sensor. Our experience over many years in optoelectronics and electronic imaging shows the superior quality of this technology and we can expect that our customers will see the difference instantly’ says Kazuhiko Takemura, Head of European Endoscope Department, FUJIFILM Europe.

World Premiere: CMOS image sensor used in flexible endoscopy
The over megapixel CMOS image sensor is used in the new gastroscopy and colonoscopy systems EG-600WR and EC-600WM/WI/WL series. By adapting a CMOS image sensor, the new 600 series endoscopes enable super-high resolution images to be produced. The leading-edge CMOS technology realizes less noise and brilliant images by converting the analog signal to digital in the tip of the scope. During transmission the digital signal is much less affected by any noise from the outside. CMOS Technology also realizes 60 frame progressive video.

Close focus up to 2 mm and improved FICE image

The focus at the edges of an image has been improved, minimizing distortion in observation of a lumen. Through a combination with the megapixel CMOS image sensor, high performance optical system assists various observations ranging from close-up to distant views. Through higher resolution and improved noise reduction, FICE images are more sharp and clear than ever. It enables easier differentiation between lesion-affected and non-affected tissue.

Coloassist II for better insertion into the colon
By adopting ColoAssist II in EC-600WM/WI/WL both force and torque transmission have been improved. Compared to the previous type, gradual stiffness level has been adjusted: it is softer at the distal and harder at operating side, resulting in more efficient transmission.

Double Balloon Endoscopy: new horizons in therapeutic treatments in the small intestine
In 2004 double-balloon endoscopy allowed Fujifilm to turn a long-held dream into reality: the possibility of examining and treating the entire small intestine. The new Double Balloon Endoscope EN-580T is now added to Fujifilm’s line-up of double-balloon endoscopes which has greatly contributed to precise diagnosis and treatment for diseases of the small intestine. A large forceps channel of 3.2 mm provides greater suction performance. The integrated Super CCD sensor ensures vivid and high quality images. Used in combination with FICE the EN-580T enables easier differentiation between lesion-affected and non-affected areas. A newly designed one-touch connector and relocated balloon air feed inlet provides for better operability.

Symposium and booth lectures at UEG week
In addition to the product demonstrations at the booth, Fujifilm will host a Symposium on 14 October under the title ‘New horizons in GI screening and therapeutic endoscopy’.

In addition, booth lectures will be given at 10:35 -11:00, on 14th and 15th October 2013 dedicated to the first clinical experience with 600 series and BEACON needle.

About Fujifilm Medical Systems
Fujifilm is a pioneer in digital diagnostic imaging, and is expanding into the areas of preventive healthcare and treatment. The portfolio consists of Digital Imaging solutions for diagnostics, medical picture archiving and communication systems (PACS), computed radiography, digital radiography, digital mammography, dry imagers, x-ray film and screen, endoscopy systems, clinical chemistry analysers, ultrasound systems, and related equipment technical service as well as technical application support. For more information, please visit www.fujifilm.eu/medical.

Fujifilm Announces CMOS Sensor for Endoscopy

In consumer applications this Fujufilm’s announcement would sound like from 10 years ago. But medical market is different: “Fujifilm is proud to make use of the over-megapixel customised CMOS sensor. Our experience over many years in optoelectronics and electronic imaging shows the superior quality of this technology and we can expect that our customers will see the difference instantly” says Kazuhiko Takemura, Head of European Endoscope Department, Fujifilm Europe.

By adapting a CMOS image sensor, Fujifilm’s 600 series endoscopes enable super-high resolution images to be produced. The leading-edge CMOS technology realizes less noise and brilliant images by converting the analog signal to digital in the tip of the scope. During transmission the digital signal is much less affected by any noise from the outside. CMOS technology also realizes 60fps progressive video.

New Market Study Published: Richard Wolf GmbH Market Share Analysis

GlobalData’s new report, “Richard Wolf GmbH Market Share Analysis” provides in-depth information on Richard Wolf GmbH’s market position in the different medical equipment markets it operates in. The report provides Richard Wolf GmbH market share information in two key market categories – Rigid Endoscopes and Flexible Endoscopes. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

– Global company shares (in Revenues) information for the key markets Richard Wolf GmbH operates in – Endoscopy Devices.
– Richard Wolf GmbH’s company shares (in Revenues) information for all the key countries the company has presence in – India, Australia, Italy, United Kingdom, Germany, France, Spain, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates, Canada, Mexico, United States and Brazil.
– Richard Wolf GmbH’s company shares (in Revenues) information for all the key market categories the company has presence in – Rigid Endoscopes and Flexible Endoscopes.
– All the key data-points are for 2012 and cover all the key regions – North America, Europe, Asia-Pacific, Middle East and Africa and South and Central America.
– Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
– The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..
– Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

12 Spine Surgeon Instructors of Endoscopic Techniques

John C. Chiu, MD (California Spine Institute Medical Center, Los Angeles). Dr. Chiu has conducted several courses in endoscopic spine surgery and is considered a pioneer in the field. He is president of the California Spine Institute Medical Center and founding chairman of the American Academy of Minimally Invasive Spinal Surgery and Medicine. In addition to his clinical work, Dr. Chiu participates in minimally invasive spine surgery research, development and education. He has also served as president of the International Society of Minimally Invasive Spine Surgery and a professor of minimally invasive spine surgery at several institutions internationally. He was involved in development of robotic surgery and telesurgery, and advocates for redefining the algorithm for treating degenerative spinal disorders and spinal segmentation motion preservation with minimally invasive techniques. Dr. Ghiu earned his medical degree at Baylor University College of Medicine in Houston and completed his neurosurgical training at Mayo School of Medicine in Rochester, Minn. His additional training includes fellowships at State University of New York, University of Zurich and University of Lund in Sweden.

Richard Fessler, MD (Northwestern Memorial Hospital). 
Dr. Fessler is a member of the Northwestern Medical Faculty Foundation and former chief of neurological surgery at the University of Chicago. He has extensive experience in minimally invasive spine surgery and pioneered endoscopic techniques such as microendoscopic discectomy with applications for the anterior and posterior cervical spine. He has authored and edited textbooks on spine surgery techniques and outpatient procedures, as well as published more than 60 peer reviewed papers. He has served on the board of two neurosurgical and spine journals and directs several spine surgery courses each year. In addition to his clinical practice, Dr. Fessler directs research projects on topics such as technique development for minimally invasive spine surgery and human embryonic spinal cord treatment for spinal cord injury. Dr. Fessler earned his medical degree at the University of Chicago and completed his fellowship in neurosurgery at the University of Chicago Medical Center.

Melvin Field, MD (Orlando Neurosurgery). 
Dr. Field has served as an instructor at nation-wide forums for teaching advanced minimally invasive endoscopic neurosurgery, complex spine surgery and image-guided stereotactic neurosurgery. His research interests include neurosurgical management of elite athletes and treatment of sports-related concussions. He is currently involved in developing a less-invasive surgical procedure for athletes to return to play quicker after spine surgery and another project to better understand the biomechanics of golf-related spinal disorders. Dr. Field is a member of North American Spine Society, American Association of Neurological Surgeons and Congress of Neurological Surgeons. He earned his medical degree at the University of Florida and completed his residency in neurosurgery at the University of Pittsburgh Medical Center.

Choll W. Kim, MD (Spine Institute of San Diego).
 Dr. Kim is a spine surgeon with Spine Institute of San Diego and director of the Minimally Invasive Spine Center at Alvarado Hospital in San Diego. He has a professional interest in minimally invasive spine surgery using image guidance and navigation technologies, and he has been instrumental in educating other spine surgeons on endoscopic technique. In addition to his clinical practice, Dr. Kim is a founder of the Society for Minimally Invasive Spine Surgery and a member of North American Spine Society. Previously, he was a voting member of the FDA Orthopaedic Devices Panel and past president of the San Diego Chapter of Western Orthopaedic Associations. Dr. Kim earned his medical degree from Harvard Medical School in Boston and completed his fellowship in complex spine surgery at Mayo Clinic in Rochester, Minn.

Kai-Uwe Lewandrowski, MD (Center for Advanced Spinal Surgery of Southern Arizona, Tucson).
 Dr. Lewandrowski is in private practice at the Center for Advanced Spinal Surgery of Southern Arizona and has spent time instructing surgeons on endoscopic spine surgery technique. In addition to his clinical work, Dr. Lewandrowski has authored several papers and book chapters on spine-related topics. He holds patents for his innovations and is constantly focused on improving clinical outcomes while minimizing the impact of spine surgery. Dr. Lewandrowski earned his medical degree at Ruhr University in Germany and Boston University. His additional training includes the Harvard Combined Orthopaedic Residency Program and a spine surgery fellowship at Cleveland Clinic.

Bryan J. Massoud, MD (Spine Centers of America, Fair Lawn, N.J.).
 Dr. Massoud founded Spine Centers of America and has performed thousands procedures using endoscopic techniques for spinal surgery, including for patients with disc herniations, spinal stenosis, scoliosis, infections and failed back surgery. He also spends time conducting workshops for other surgeons on endoscopic technique. In addition to his clinical practice, Dr. Massoud is a member of the North American Spine Society and American Academy of Orthopaedic Surgeons. He earned his medical degree at Robert Wood Johnson Medical School in New Jersey and completed an orthopedic surgery residency at St. Joseph’s Hospital and Medical Center in New Jersey. His additional training includes a fellowship in spine surgery at Texas Back Institute in Plano and further experience in endoscopic spine surgery under Dr. Martin Knight in England.

Tony Mork, MD (Newport Beach, Calif.). 
Dr. Mork has performed more than 8,000 endoscopic spine surgeries in his career as well as designed specialized tools for spinal procedures. He was instrumental in developing current endoscopic spine surgery techniques and was the founder of the Endoscopic Spinal Academy. Throughout his career, Dr. Mork has instructed other surgeons in endoscopic techniques and continues looking ahead to new procedures and techniques. He now does spinal mapping to diagnose his patients before treatment. Dr. Mork earned his medical degree at Creighton University in Omaha.

Said Osman, MD (American Spine, Frederick, Md.). 
Dr. Osman is an orthopedic surgeon with a special interest in spine surgery. His mission has been to pioneer micro-spine surgery, minimally invasive spine surgery and endoscopic spine surgery, and he participates as an instructor in an Advanced Transforaminal Endoscopic Spine Training Workshop on the maxMorespine System. During his career, he has been involved in the development of the Uni-directional Dynamic Spinal Fixation Device and Biologic Intramedullary Fixation device. In addition to his clinical practice, Dr. Osman participates in research and has been recognized by several professional organizations. Dr. Osman earned his medical degree at the University of Nairobi in Kenya and completed fellowship training at The Royal College of Surgeons

Noel Perin, MD (NYU Langone, New York City). Dr. Perin is the director of spine and minimally invasive surgery in the department of neurosurgery at NYU Langone Medical Center. He has served on the faculty of a hands-on course for endoscopic spine surgery approaches and director of a course on minimally invasive lumbar spine surgery. In addition to his clinical practice, Dr. Perrin engages in spine-related research and has presented his research nationally. He is a member of the American Board of Neurological Surgeons and American College of Surgeons. Dr. Perin earned his medical degree at the University of Colombo Faculty of Medicine in Sri Lanka and completed his neurosurgery residency at New York University Medical Center. His additional training includes spine surgery fellowships at New York University Medical Center and in West Germany.

William O. Reed, Jr., MD (Merriam, Kan.). 
Dr. Reed travels nationally and internationally to instruct and educate surgeons in minimally invasive and laparoscopic spine surgery techniques. He is a clinical instructor and consultant for many companies and has a professional interest in advancing spinal surgery techniques. He performs endoscopic spine surgery and outpatient surgery for herniated lumbar discs. Dr. Reed earned his medical degree at the University of Missouri-Columbia Medical School and completed his residency at Cabarrus Memorial Hospital. His additional training includes a fellowship at Duke University Hospital in Durham, N.C.

Farhan N. Siddiqi, MD (Trinity Spine Center, Odessa, Fla.).
 Dr. Siddiqi is a fellowship-trained endoscopic and reconstructive spine surgeon. He instructs on his technique in courses across the country and is a member of several professional societies, including North American Spine Society and American Academy of Orthopaedic Surgeons. He is the co-founder of Trinity Spine and an assistant professor at the University of Southern Florida Medical School in Tampa. Dr. Siddiqi earned his medical degree at Cornell University Medical College in New York City and completed his residency at Long Island Jewish Medical Center. His additional training includes a fellowship at Desert Institute for Spine Care in Phoenix.

Anthony T. Yeung, MD (Desert Institute for Spine Care, Phoenix). 
Dr. Yeung is the founder of Desert Institute for Spine Care and developer of the Yeung Endoscopic Spine System. The system includes multi-channel spine endoscopes and related instruments by Richard Wolf Surgical Instrument Company. He has instructed surgeons on his endoscopic technique from around the world. During his career, Dr. Yeung has served in leadership positions with the North American Spine Society and American Academy of Orthopaedic Surgeons, as well as president of the American Academy for Minimally Invasive Spinal Medicine and Surgery. Dr. Yeung earned his medical degree at the University of New Mexico School of Medicine and completed his residency in orthopedic surgery at Maricopa County General Hospital in Phoenix.

ISG secures £1.4 million Dundee office scheme

ISG has been appointed by medical equipment manufacturer and supplier, KARL STORZ Endoscopy UK Ltd, to undertake a £1.4 million project to expand the company’s Scottish facility.

The 47-week, dual-phased scheme will see ISG substantially increasing office accommodation and demonstration facilities at the KARL STORZ site in Thomas Wise Place, Dundee. The initial phase of the development involves the construction of a 12,900 sq. ft. steel frame office extension, with render, facing brick and cladding to its façade and a section of curtain walling showcasing a new feature stairwell. In order to boost the overall sustainable credentials of the building, the new structure will also include a planted green roof to absorb CO2 and other pollutants, and reduce the impact of surface run off.

The extension will be fitted out to create contemporary open plan office space. Upon completion of this first phase, staff will then relocate into the new accommodation to allow the commencement of the second phase of the redevelopment. During this final 12-week programme, ISG will comprehensively refurbish and reconfigure the existing office building to create a high specification Sales and Demonstration area. The contractor will install a number of new windows to maximise the volume of natural daylight entering the building, as well as replacing all existing glazing with modern, high performance units.

ISG’sAndy Mallice, managing director – Scotland, commented: “This latest win represents a significant addition to our growing client base and further demonstrates our ability to successfully convert opportunities across multiple industry sectors. It is particularly pleasing to support successful international businesses with a strong Scottish presence, and we are confident that these new facilities will further underpin KARL STORZ’s plans for the future.”

Wellwood Leslie Chartered Architects and Chartered Quantity Surveyors, Christie and Partners have also been appointed to work on the project.

Upon completion of the works, matters relating to Finance, IT and Quality and Environmental Compliance will be overseen from KARL STORZ’s operation in Dundee.